Redefining second-line treatment strategy, sequencing, and real-world implementation in relapsed/refractory multiple myeloma: insights from the 31st Annual Congress of the European Hematology Association

Clin Adv Hematol Oncol. 2026 Sep;24(6 Suppl 8):1-14.ABSTRACTThe management of relapsed/refractory (R/R) multiple myeloma (MM) continues to evolve with the introduction of novel therapies and the use of newer therapies in different treatment settings and combinations. Chimeric antigen receptor (CAR)

A Ajai Chari

Hopes and doubts about zilebesiran, a new antihypertensive drug

Wiad Lek. 2026;79(7):1646-1653. doi: 10.36740/WLek/221451.ABSTRACTThe aim of this work is to critically evaluate the benefits and risks of zilebesiran. A comprehensive literature search was conducted in PubMed and Google Scholar databases to identify relevant studies on zilebesiran and other small-i

J Jerzy Głuszek

DEPP: A diabetes exercise prescription protocol knowledge base

PLOS Digit Health. 2026 Sep 16;5(9):e0001728. doi: 10.1371/journal.pdig.0001728. eCollection 2026 Sep.ABSTRACTExercise plays a critical role in diabetes management by improving glycemic control and reducing cardiovascular risk. However, personalizing exercise prescriptions to individual characterist

T Ting Bao

Heart rate variability and baroreflex sensitivity derived from finger photoplethysmography during dynamic cerebral autoregulation assessments: Association with age, sex and time of day in healthy volunteers

Physiol Int. 2026 Sep 16:2060.2026.00860. doi: 10.1556/2060.2026.00860. Online ahead of print.ABSTRACTPURPOSE: Assessing dynamic cerebral autoregulation (dCA) noninvasively includes continuous blood pressure recording with a photoplethysmography device. We investigated in this retrospective study wh

M Manuel Bolognese